Home > Cashflow Statement > MARKSANS PHARMA

MARKSANS PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-71 Cr₹-65 Cr₹-69 Cr₹198 Cr₹80 Cr

What is the latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA ?

The latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA is ₹-71 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-71 Cr
Mar2025₹-65 Cr
Mar2024₹-69 Cr
Mar2023₹198 Cr
Mar2022₹80 Cr

How is Cash Flow from Financing Activities of MARKSANS PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-71 Cr
Negative
Mar2025 ₹-65 Cr
Negative
Mar2024 ₹-69 Cr
Negative
Mar2023 ₹198 Cr
148.81
Mar2022 ₹80 Cr -

Compare Cash Flow from Financing Activities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹14,280.3 Cr 3.2% -3.1% 70.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹425,150.0 Cr 0.8% -2.1% 4.8% Stock Analytics
DIVIS LABORATORIES ₹266,265.0 Cr 4.9% 7.9% 54.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr 1.6% -2.7% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹114,351.0 Cr 2.6% 14.2% 3.9% Stock Analytics
CIPLA ₹112,474.0 Cr 2.4% 3.4% -12% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

3.2%

-3.1%

70.4%

SENSEX

4.5%

6.1%

-9.3%


You may also like the below Video Courses